https://data.archives-ouvertes.fr/author/854064

https://data.archives-ouvertes.fr/author/854064

http://xmlns.com/foaf/0.1/topic_interest Outcomes
http://xmlns.com/foaf/0.1/interest https://data.archives-ouvertes.fr/subject/sdv.sp.pharma
http://xmlns.com/foaf/0.1/name Stéphane Oudard
http://xmlns.com/foaf/0.1/topic_interest Immunotherapy
http://xmlns.com/foaf/0.1/topic_interest Radioimmunotherapy
http://xmlns.com/foaf/0.1/topic_interest Efficacy
http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://xmlns.com/foaf/0.1/Person
http://xmlns.com/foaf/0.1/topic_interest Chemotherapy
http://xmlns.com/foaf/0.1/topic_interest Prognostic factor
http://xmlns.com/foaf/0.1/interest https://data.archives-ouvertes.fr/subject/info.info-bi
http://xmlns.com/foaf/0.1/topic_interest Radiotherapy
http://xmlns.com/foaf/0.1/interest https://data.archives-ouvertes.fr/subject/stat.me
http://xmlns.com/foaf/0.1/topic_interest Immune-related adverse events
http://xmlns.com/foaf/0.1/interest https://data.archives-ouvertes.fr/subject/math.math-st
http://xmlns.com/foaf/0.1/topic_interest Adverse event
http://xmlns.com/foaf/0.1/topic_interest Prostate cancer
http://xmlns.com/foaf/0.1/topic_interest Taxanes
http://xmlns.com/foaf/0.1/topic_interest Intensive care
http://xmlns.com/foaf/0.1/familyName Oudard
http://xmlns.com/foaf/0.1/topic_interest Biomarker
http://xmlns.com/foaf/0.1/interest https://data.archives-ouvertes.fr/subject/sdv.mhep.heg
http://xmlns.com/foaf/0.1/topic_interest Cancer
http://xmlns.com/foaf/0.1/topic_interest Hormone therapy
http://xmlns.com/foaf/0.1/topic_interest Single nucleotide polymorphisms
http://xmlns.com/foaf/0.1/interest https://data.archives-ouvertes.fr/subject/sdv.mhep.un
http://xmlns.com/foaf/0.1/topic_interest Angiogenesis inhibitor
http://xmlns.com/foaf/0.1/interest https://data.archives-ouvertes.fr/subject/sdv.mhep.phy
http://xmlns.com/foaf/0.1/topic_interest Immune checkpoint inhibitor
http://xmlns.com/foaf/0.1/topic_interest Immune checkpoint inhibitors
http://xmlns.com/foaf/0.1/topic_interest Combination therapy
http://xmlns.com/foaf/0.1/interest https://data.archives-ouvertes.fr/subject/sdv.bibs
http://xmlns.com/foaf/0.1/topic_interest Phytogenic/adverse effects Case-Control Studies Female Freezing Gloves
http://xmlns.com/foaf/0.1/topic_interest Elderly
http://xmlns.com/foaf/0.1/interest https://data.archives-ouvertes.fr/subject/sdv.imm
http://xmlns.com/foaf/0.1/interest https://data.archives-ouvertes.fr/subject/sdv.can
http://xmlns.com/foaf/0.1/interest https://data.archives-ouvertes.fr/subject/info.info-gt
http://xmlns.com/foaf/0.1/topic_interest Heterogeneity
http://xmlns.com/foaf/0.1/interest https://data.archives-ouvertes.fr/subject/scco.comp
http://xmlns.com/foaf/0.1/mbox_sha1sum f7789e1b6f2d34d2ad025c9268368814
http://xmlns.com/foaf/0.1/topic_interest Abiraterone acetate
http://xmlns.com/foaf/0.1/interest https://data.archives-ouvertes.fr/subject/info.info-mo
http://xmlns.com/foaf/0.1/topic_interest Mitoxantrone
http://xmlns.com/foaf/0.1/topic_interest Outcome
http://xmlns.com/foaf/0.1/topic_interest French GETUG consortium
http://xmlns.com/foaf/0.1/topic_interest Adult Aged Antineoplastic Agents
http://xmlns.com/foaf/0.1/topic_interest Metastatic castration-resistant prostate cancer
http://xmlns.com/foaf/0.1/firstName Stéphane
http://xmlns.com/foaf/0.1/topic_interest Immunogenic cell death
http://xmlns.com/foaf/0.1/interest https://data.archives-ouvertes.fr/subject/sdv.bc.ic
http://xmlns.com/foaf/0.1/topic_interest Cancer treatment
http://xmlns.com/foaf/0.1/topic_interest Prognosis
http://xmlns.com/foaf/0.1/topic_interest Protective Humans Male Middle Aged Nail Diseases/chemically induced/prevention & control Skin Diseases/chemically induced/prevention & control Taxoids/adverse effects
http://xmlns.com/foaf/0.1/topic_interest Small cell bladder cancer

Télécharger au format